Jay S. Cooper

31.2k total citations · 14 hit papers
154 papers, 22.7k citations indexed

About

Jay S. Cooper is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jay S. Cooper has authored 154 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Otorhinolaryngology, 48 papers in Surgery and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jay S. Cooper's work include Head and Neck Cancer Studies (75 papers), Lung Cancer Treatments and Mutations (22 papers) and Head and Neck Surgical Oncology (19 papers). Jay S. Cooper is often cited by papers focused on Head and Neck Cancer Studies (75 papers), Lung Cancer Treatments and Mutations (22 papers) and Head and Neck Surgical Oncology (19 papers). Jay S. Cooper collaborates with scholars based in United States, Puerto Rico and Switzerland. Jay S. Cooper's co-authors include Thomas F. Pajak, Arlene A. Forastiere, John F. Ensley, Muhyi Al‐Sarraf, Randal S. Weber, Karen K. Fu, John A. Ridge, Andy Trotti, Arnold Herskovic and Roger W. Byhardt and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and JAMA.

In The Last Decade

Jay S. Cooper

150 papers receiving 22.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

2004 2.3k citations Jay S. Cooper, Thomas F. Pajak et al. New England Journal of Medicine profile →
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

2003 2.3k citations Arlene A. Forastiere, Helmuth Goepfert et al. New England Journal of Medicine profile →
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

1998 1.7k citations Muhyi Al‐Sarraf, K.K. Fu et al. Journal of Clinical Oncology profile →
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus

1992 1.6k citations Arnold Herskovic, Muhyi Al‐Sarraf et al. New England Journal of Medicine profile →
Chemoradiotherapy of Locally Advanced Esophageal Cancer

1999 1.5k citations Jay S. Cooper, Arnold Herskovic et al. profile →
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

2005 1.2k citations Jay S. Cooper, Thomas F. Pajak et al. Head & Neck profile →
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

2008 1.0k citations Mitchell Machtay, Randal S. Weber et al. Journal of Clinical Oncology profile →
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

2000 983 citations Karen K. Fu, Thomas F. Pajak et al. International Journal of Radiation Oncology*Biology*Physics profile →
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

2012 835 citations Arlene A. Forastiere, Randal S. Weber et al. Journal of Clinical Oncology profile →
Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01

2004 771 citations Kathryn Winter, Jay S. Cooper et al. Journal of Clinical Oncology profile →
Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival

2006 626 citations Jay S. Cooper et al. profile →
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

1997 525 citations Muhyi Al‐Sarraf, Arnold Herskovic et al. Journal of Clinical Oncology profile →
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines

2003 522 citations Kian Ang, Jay S. Cooper et al. profile →
Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

2012 385 citations Jay S. Cooper, Thomas F. Pajak et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Jay S. Cooper

Since Specialization

Citations

This map shows the geographic impact of Jay S. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay S. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay S. Cooper more than expected).

Fields of papers citing papers by Jay S. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay S. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay S. Cooper. The network helps show where Jay S. Cooper may publish in the future.

Co-authorship network of co-authors of Jay S. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Jay S. Cooper. A scholar is included among the top collaborators of Jay S. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay S. Cooper. Jay S. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Matthew C. Ward, Shlomo A. Koyfman, Richard L. Bakst, Danielle N. Margalit, Beth M. Beadle, Jonathan J. Beitler, Steven S. Chang, Jay S. Cooper, Thomas J. Galloway, John A. Ridge, Jared R. Robbins, Assuntina G. Sacco, C. Jillian Tsai, Sue S. Yom, Farzan Siddiqui	27
2	Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary 2020 ·Head & Neck ·C. Jillian Tsai, Thomas J. Galloway, Danielle N. Margalit, Richard L. Bakst, Beth M. Beadle, Jonathan J. Beitler, Steven Chang, Allen M. Chen, Jay S. Cooper, Shlomo A. Koyfman, John A. Ridge, Jared R. Robbins, Minh Tam Truong, Sue S. Yom, Farzan Siddiqui	21
3	Feasibility of using administrative claims data for cost-effectiveness analysis of a clinical trial 2008 ·Journal of Medical Economics ·André Konski, Mythreyi Bhargavan, Jean B. Owen, Rebecca Paulus, Jay S. Cooper, Karen K. Fu, Kian Ang, Deborah Watkins Bruner	3
4	The TAME Risk Classification System: Acute Toxicity Burden and IPD Analysis of RTOG 90–03 2005 ·International Journal of Radiation OncologyBiologyPhysics ·T F Pajak, Andy Trotti, Clement K. Gwede, Rebecca Paulus, Jay S. Cooper, John A. Ridge, K.K. Fu, K. Kian Ang	1
5	Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03 2005 ·Head & Neck ·Rachel Rabinovitch, Barbara L. Grant, Brian Berkey, David Raben, Kie Kian Ang, Karen K. Fu, Jay S. Cooper, (unknown)	86
6	Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck breakdown → 2004 ·New England Journal of Medicine ·Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, Joseph B. Jacobs, Bruce H. Campbell, Scott Saxman, Julie A. Kish, Harold E. Kim, Anthony J. Cmelak, Marvin Rotman, Mitchell Machtay, John F. Ensley, K. S. Clifford Chao, Christopher J. Schultz, Nancy Y. Lee, Karen K. Fu	2295
7	Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer breakdown → 2003 ·New England Journal of Medicine ·Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor, Thomas F. Pajak, Randal S. Weber, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, C. Chao, (unknown), Ding-Jen Lee, Andrea Leaf, John F. Ensley, Jay S. Cooper	2262
8	Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer Committee. 2001 ·PubMed ·(unknown), (unknown), Everett E. Vokes, A. Trotti, (unknown), Jay S. Cooper, A. Forastiere, (unknown), Elizabeth Hammond, Fadlo R. Khuri, (unknown), (unknown), (unknown), C. Mack, (unknown), (unknown), (unknown)	4
9	Irradiation with or without misonidazole for patients with stages IIIb and IVa carcinoma of the cervix: final results of RTOG 80-05 1999 ·International Journal of Radiation OncologyBiologyPhysics ·Perry W. Grigsby, Kathryn Winter, Todd H. Wasserman, Víctor A. Marcial, Marvin Rotman, Jay S. Cooper, Henry Keys, Sucha O. Asbell, Theodore L. Phillips	42
10	THE EVOLUTION OF THE ROLE OF RADIATION THERAPY IN THE MANAGEMENT OF MUCOCUTANEOUS MALIGNANT MELANOMA 1998 ·Hematology/Oncology Clinics of North America ·Jay S. Cooper, (unknown)	7
11	Evolution of the radiation therapy oncology group clinical trials for head and neck cancer 1996 ·International Journal of Radiation OncologyBiologyPhysics ·Karen K. Fu, Jay S. Cooper, Víctor A. Marcial, George E. Laramore, Thomas F. Pajak, Joseph B. Jacobs, Muhyi Al‐Sarraf, Arlene A. Forastiere, James D. Cox	40
12	Lea's Shield®: A study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide 1996 ·Contraception ·Christine Mauck, Lucinda Glover, Eric A. Miller, Susan Allen, David F. Archer, Paul D. Blumenthal, BRUCE A. ROSENZWEIG, Rosalie Dominik, (unknown), Jay S. Cooper, (unknown), (unknown), Henry Gabelnick	32
13	Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04 1992 ·American Journal of Clinical Oncology ·William T. Sause, Charles Scott, Samuel G. Taylor, Roger W. Byhardt, (unknown), John W. Thomson, Thomas K. Jones, Jay S. Cooper, Robert D. Lindberg	42
14	Elapsed treatment days—A critical item for radiotherapy quality control review in head and neck trials: RTOG report 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Thomas F. Pajak, (unknown), Víctor A. Marcial, John T. Fazekas, Jay S. Cooper, Philip Rubin, Walter J. Curran, Lawrence W. Davis	138
15	The relationship of nasopharyngeal carcinomas and second independent malignancies based on the radiation therapy oncology group experience 1991 ·Cancer ·Jay S. Cooper, Charles Scott, Víctor A. Marcial, Thomas W. Griffin, John T. Fazekas, George E. Laramore, (unknown)	30
16	Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the radiation therapy oncology group study 81-17 1990 ·Cancer ·Víctor A. Marcial, Thomas F. Pajak, Mohammed Mohiuddin, Jay S. Cooper, (unknown), Phyllis Ager Mowry, Walter J. Curran, John D. Crissman, Marisol Rodrı́guez, (unknown)	164
17	Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. 1990 ·Journal of Clinical Oncology ·Muhyi Al‐Sarraf, T F Pajak, Jay S. Cooper, Majid Mohiuddin, Arnold Herskovic, Phyllis J. Ager	115
18	Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience 1989 ·International Journal of Radiation OncologyBiologyPhysics ·Jay S. Cooper, Thomas F. Pajak, Philip Rubin, Leslie Tupchong, Luther W. Brady, Steven A. Leibel, George E. Laramore, Víctor A. Marcial, Lawrence W. Davis, James D. Cox	307
19	The influence of dose on the long-term control of classic (non-aids associated) Kaposi's sarcoma by radiotherapy 1988 ·International Journal of Radiation OncologyBiologyPhysics ·Jay S. Cooper	23
20	CT detection of cerebral metastases inapparent on magnetic resonance imaging scan 1988 ·Journal of Computed Tomography ·Jay S. Cooper, Joseph Ransohoff, Stephen Rush, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact